Login to Your Account

ZymoGenetics Gets Sales Help In $198M Thrombin Collaboration

By Jim Shrine

Wednesday, June 20, 2007
ZymoGenetics Inc. signed on a partner for its recombinant human thrombin product and with the deal expects to get $70 million this year along with some marketing muscle as it prepares for an anticipated sales battle with Johnson & Johnson.(BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription